Takeda names GSK vaccine chief as COO; PharmAthene backs out of Theraclone merger;

> Takeda has named the president of GlaxoSmithKline's ($GSK) vaccine unit as its COO. News (sub. req.)

> PharmAthene ($PIP) is backing out of its proposed merger with Theraclone. Article

> Regulators in the Philippines have found counterfeit rabies vaccines. Item

> CMC Biologics is to manufacture a placental malaria vaccine. Release

> Sex and money are just two of several issues holding back HPV vaccines, research shows. Piece

> Only half of U.K. healthcare workers receive a routine flu vaccination. Article

> Korean CRO SillaJen has bought failed cancer vaccine Pexa-Vec. News

> The European CHMP has backed a two-dose regimen of GlaxoSmithKline's HPV vaccine. Item

> Immunicum has reported positive early-phase data for its therapeutic cancer vaccine. Release